Dengue in India: Understanding the Drivers of a Rising Burden & Evolving Patterns Dr K. Muruganandam15 Jun 2026 12:30 PM ISTIndia has reported more than ten-fold rise in reported dengue cases, from 28,066 cases in 2010 to 2,89,235 cases in 2023 (1). Although reported...
Elecoglipron Produces Significant Weight Loss and Improves Glycemic Control in Phase II Trials Dr Kartikeya Kohli15 Jun 2026 9:00 AM ISTTreatment with the investigational oral GLP-1 receptor agonist elecoglipron resulted in meaningful weight loss in individuals with obesity and...
GLP-1 Therapy Linked to 41 Percent Lower Risk of Obesity-Related Cancers: Study Dr Kartikeya Kohli13 Jun 2026 9:00 AM ISTTaiwan: In a large propensity-matched cohort study, patients receiving GLP-1 receptor agonists for obesity experienced a 41% lower risk of...
Preoperative PTH and ALP: Clinical Markers for Predicting Persistent Postoperative Hypocalcemia, Suggests Study Aashi verma12 Jun 2026 8:30 PM ISTA recent retrospective observational cohort study published in the Indian Journal of Surgery in May 2026 reveals that nearly one-third of Indian...
Finerenone Slows Kidney Function Decline and Lowers Cardio-Renal Risk in Non-Diabetic CKD: Major Trial Dr. Kamal Kant Kohli12 Jun 2026 8:15 PM ISTFinerenone significantly slowed kidney function decline and reduced the risk of cardiovascular-kidney outcomes in adults with non-diabetic chronic...
Mazdutide Produces Significant Weight Loss in Adults with Obesity: JAMA Dr Kartikeya Kohli12 Jun 2026 11:15 AM ISTA study found that mazdutide, a once-weekly glucagon and GLP-1 receptor dual agonist, led to clinically meaningful weight reduction in Chinese...
From Monotherapy to Multi-Drug Regimens: Metformin's Role as the Therapeutic Backbone for Over Seven Decades Dr. RITESH KU. AGRAWALA12 Jun 2026 10:41 AM ISTFor over six decades, metformin has remained the cornerstone of T2DM management as monotherapy and in combination with other glucose-lowering drugs. ...
Type 1 Diabetes Linked to Higher Risk of Major Femur and Hip Fractures: Study Dr Kartikeya Kohli12 Jun 2026 9:00 AM ISTDenmark: A large nationwide Danish study has revealed that older adults with type 1 diabetes have a significantly higher risk of hip, subtrochanteric,...
Vegetable Intake with Bread Reduces Postprandial Glucose and Insulin compared to bread alone: Study Dr Kartikeya Kohli11 Jun 2026 9:00 AM ISTA new study published in the journal of BMC Research Notes found that consumption of bread along with vegetable salad significantly lowered...
CagriSema Significantly Improves Glycemic Control and Weight Loss in Type 2 Diabetes: Lancet Dr Kartikeya Kohli10 Jun 2026 11:30 AM ISTUSA: A once-weekly fixed-dose combination of the novel amylin analog cagrilintide and the GLP-1 receptor agonist semaglutide (CagriSema) significantly...
Dapagliflozin and Metformin in T2D: Three Important Indian Evidences Revisited- Dr Semanti Chakraborty Swapnil Sharma10 Jun 2026 11:09 AM ISTIndia's Type 2 diabetes(T2D) prevalence is increasing, with over half of affected individuals remaining undiagnosed. More than 70% of Indian T2D...
Ozempic, GPL-1s may help curb substance use disorders, UTEP study finds Dr. Kamal Kant Kohli9 Jun 2026 8:45 PM ISTA new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated...
